SugaROx develops next-generation crop biostimulants centered on a proprietary form of the natural plant sugar trehalose-6-phosphate (T6P), using patented technology from the University of Oxford and Rothamsted Research. Its platform enables delivery of natural molecules that regulate intracellular pathways in plants via standard agronomic practices. The company has scaled synthesis from laboratory to a pilot facility in the UK and has extended field testing across multiple markets. SugaROx plans to expand field trials to validate performance, generate regulatory data, and pursue commercial launches in the UK, EU and US. Financially, the company recently closed a £2.5M Series A investment with prior seed backing of £400k from The Mosaic Company in 2025. The company is led by CEO Mark Robbins.

Total raised

$5M

Funding rounds

2

Latest round

Series A

Latest activity

May 2026